Global immunomodulators market is expected to witness a significant growth over the coming seven years owing to increasing prevalence rate of chronic diseases such as multiple sclerosis, cancer, asthma and allergies caused by mold spores, insect venom and dust mites. Immunomodulators are the fundamental agents of immunotherapy that stimulates the immune system. Immunomodulators may show high efficacy rate if used in combination with conventional treatment methods. These devices are an attractive approach as they are less costly than available drugs in the market thereby increasing the demand for immunomodulators over the forecast period.
View Full Report with TOC at:
The entire immunomodulators market is bifurcated into immunosuppressants (antimetabolites, antibodies, interferon beta, glucocorticoids and calcineurin inhibitors) and immunostimulators (vaccines, interferon alpha and antibodies). Immunosuppressants have a broader spectrum for drugs in the pipeline such as antiproliferative drugs and antimetabolite drugs. Antimetabolites are expected to gain a wider share in the market as they inhibits induction of hypersensitivity which is a common skin disease. Immunostimulants are anticipated to register greater market share owing to its increased usage in the treatment of multiple sclerosis and increasing incidence rate of cancer and allergies.
Continuous research is going on with respect to immunomodulators in other medical conditions such as diabetes and Alzheimer’s disease. North America held the highest market share pertaining to factors such as favorable government policies and high incidence rates of cancer and asthma. European market also witnessed a significant growth due to increasing awareness among people. The Asia pacific region is expected to witness fastest growth due to rising geriatric population base in India and China and increasing disposable income of its citizens. Latin America market may witness steady growth owing to less awareness for healthcare facilities.
Some prominent players operating in immunomodulators market are Novartis, Merck, Johnson and Johnson, Biogen Idec, Bristol-Myers Squibb, Abbott, Amgen Eli Lilly and Hoffman La Roche. These market players are entering into various strategic agreements, adopting competitive marketing strategies and R&D operations. For example, Abbott entered into amarketing agreement with Biotest to market BT-061 in five European countries Germany, Spain, U.K., France and Italy. For other pharmaceutical markets, Abbott has exclusive marketing rights. These market players are also striving to develop new products to increase their market penetration.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: firstname.lastname@example.org, email@example.com
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States